1. Wnt/β-catenin signaling cascade: A promising target for glioma therapy
   Lu He et al, 2018, J Cell Physiol CrossRef
2. RNA‐Seq analysis of potential lncRNAs and genes for the anti‐renal fibrotic effect of norcantharidin
   Hengting Xiao et al, 2019, J Cell Biochem CrossRef
3. Structure, function and disease relevance of Wnt inhibitory factor 1, a secreted protein controlling the Wnt and hedgehog pathways
   Krisztina Kerekes et al, 2019, Growth Factors CrossRef
4. Native Oligodendrocytes in Astrocytomas Might Inhibit Tumor Proliferation by WIF1 Expression
   Martin Asslaber et al, 2016, J Neuropathol Exp Neurol CrossRef
5. Protein Phosphatase 2A Inhibiting β-Catenin Phosphorylation Contributes Critically to the Anti-renal Interstitial Fibrotic Effect of Norcantharidin
   Zheng Xiao et al, 2020, Inflammation CrossRef
6. Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities
   Mu-Su Pan et al, 2020, Chin Med CrossRef
7. Cantharidin inhibits melanoma cell proliferation via the miR‑21‑mediated PTEN pathway
   Zhen Mu et al, 2018, Mol Med Report CrossRef
8. Norcantharidin: research advances in pharmaceutical activities and derivatives in recent years
   Jianbo Zhou et al, 2020, Biomedicine & Pharmacotherapy CrossRef
9. Norcantharidin overcomes vemurafenib resistance in melanoma by inhibiting pentose phosphate pathway and lipogenesis via downregulating the mTOR pathway
   Lei Wang et al, 2022, Front. Pharmacol. CrossRef
10. Review targeted drug delivery systems for norcantharidin in cancer therapy
    Bing-Tao Zhai et al, 2022, J Nanobiotechnol CrossRef